Biased Signaling of CCL21 and CCL19 Does Not Rely on N-Terminal Differences, but Markedly on the Chemokine Core Domains and Extracellular Loop 2 of CCR7-Reference-Cited by-同舟云学术

Biased Signaling of CCL21 and CCL19 Does Not Rely on N-Terminal Differences, but Markedly on the Chemokine Core Domains and Extracellular Loop 2 of CCR7

Published:2019-09-13 Issue: Volume:10 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Jørgensen Astrid S.,Larsen Olav,Uetz-von Allmen Edith,Lückmann Michael,Legler Daniel F.,Frimurer Thomas M.,Veldkamp Christopher T.,Hjortø Gertrud M.,Rosenkilde Mette M.

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference54 articles.

1. CCR7 and its ligands: balancing immunity and tolerance;Förster;Nat Rev Immunol.,2008

2. Common and biased signaling pathways of the chemokine receptor CCR7 elicited by its ligands CCL19 and CCL21 in leukocytes;Hauser;J Leukoc Biol.,2016

3. Biased signaling of G protein-coupled receptors – From a chemokine receptor CCR7 perspective;Jørgensen;Gen. Comp. Endocrinol.,2017

4. Biased and G protein-independent signaling of chemokine receptors;Steen;Front Immunol.,2014

5. The T cell chemokine receptor CCR7 is internalized on stimulation with ELC, but not with SLC;Bardi;Eur J Immunol.,2001

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progress on the development of Class A GPCR‐biased ligands;British Journal of Pharmacology;2024-09-11

2. Systematic Assessment of Human CCR7 Signalling Using NanoBRET Biosensors Points towards the Importance of the Cellular Context;Biosensors;2024-03-14

3. Chemokine CCL19 promotes type 2 T-cell differentiation and allergic airway inflammation;Journal of Allergy and Clinical Immunology;2023-11

4. NMR indicates the N-termini of PSGL1 and CCR7 bind competitively to the chemokine CCL21;Biochemistry and Biophysics Reports;2023-09

5. CCL21/CCR7 axis as a therapeutic target for autoimmune diseases;International Immunopharmacology;2023-08